0001803599FALSE00018035992024-04-252024-04-25

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): October 25, 2024
CONCENTRIX CORPORATION
(Exact name of registrant as specified in its charter)

Delaware001-3949427-1605762
(State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification Number)

39899 Balentine Drive, Suite 235, Newark, California
94560
(Address of principal executive offices)(Zip Code)

(800) 747-0583
(Registrant’s telephone number, including area code)

N/A
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))



Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.0001 per shareCNXCThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company   ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐



Item 4.01. Changes in Registrant’s Certifying Accountant.

The Audit Committee (the “Audit Committee”) of the Board of Directors (the “Board”) of Concentrix Corporation (the “Company”) conducted a competitive process to determine the Company’s independent registered public accounting firm for the fiscal year ending November 30, 2025. Several firms were invited to participate in this process including KPMG LLP (“KPMG”), which has served as the Company’s independent registered public accounting firm since 2019. Following an extensive evaluation process, on October 25, 2024, the Audit Committee selected Ernst & Young LLP (“EY”) as the Company’s independent registered public accounting firm for the Company’s fiscal year ending November 30, 2025, subject to completion of EY’s standard client acceptance procedures and execution of an engagement letter. On October 28, 2024, the Company notified KPMG that the Company will dismiss KPMG as its independent registered public accounting firm upon completion of the audit of the Company’s consolidated financial statements as of and for the fiscal year ending November 30, 2024 and the effectiveness of internal control over financial reporting as of November 30, 2024 and the issuance of KPMG’s reports thereon.

The audit reports of KPMG on the Company’s consolidated financial statements as of and for the fiscal years ended November 30, 2022 and 2023 did not contain any adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principles.

During the fiscal years ended November 30, 2022 and 2023 and the subsequent interim periods through October 30, 2024, there were: (i) no disagreements within the meaning of Item 304(a)(1)(iv) of Regulation S-K and the related instructions between the Company and KPMG on any matters of accounting principles or practices, financial statement disclosure, or auditing scope or procedure which disagreements, if not resolved to KPMG’s satisfaction, would have caused KPMG to make reference thereto in their reports; and (ii) no “reportable events” within the meaning of Item 304(a)(1)(v) of Regulation S-K.

The Company provided KPMG with a copy of the disclosures it is making in this Current Report on Form 8-K prior to its filing and has requested that KPMG furnish a letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the above statements. A copy of KPMG’s letter, dated October 30, 2024, is filed as Exhibit 16.1 to this Form 8-K.

During the fiscal years ended November 30, 2022 and 2023 and the subsequent interim periods through October 30, 2024, neither the Company nor anyone on its behalf has consulted with EY regarding: (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company's financial statements, and neither a written report nor oral advice was provided to the Company that EY concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing, or financial reporting issue or (ii) any matter that was the subject of a “disagreement” (within the meaning of Item 304(a)(1)(iv) of Regulation S-K and the related instructions to that Item) or a “reportable event” (within the meaning of Item 304(a)(1)(v) of Regulation S-K).
Item 9.01.    Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.Document Description
16.1
104Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: October 30, 2024
CONCENTRIX CORPORATION
  
 By:/s/ Jane C. Fogarty
 
Jane C. Fogarty
Executive Vice President, Legal

Exhibit 16.1
October 30, 2024

Securities and Exchange Commission
Washington, D.C.20549

Ladies and Gentlemen:

We are currently principal accountants for Concentrix Corporation and, under the date of January 29, 2024, we reported on the consolidated financial statements of Concentrix Corporation as of and for the fiscal years ended November 30, 2023 and 2022, and the effectiveness of internal control over financial reporting as of November 30, 2023. On October 28, 2024, we were notified that we will be dismissed upon completion of the audit of Concentrix Corporation’s consolidated financial statements as of and for the fiscal year ended November 30, 2024, the effectiveness of internal control over financial reporting as of November 30, 2024, and the issuance of our report thereon.

We have read Concentrix Corporation’s statements included under Item 4.01 of its Form 8-K dated October 30, 2024, and we agree with such statements, except that we are not in a position to agree or disagree with Concentrix Corporation’s statements that several firms were invited to participate in a competitive bid process, the Audit Committee selected EY, and that EY’s selection is subject to its standard client acceptance procedures and the execution of an engagement letter. We are also not in a position to agree or disagree with any of Concentrix Corporation’s statements in the last paragraph relating to the Company not having consulted with Ernst & Young LLP during the periods indicated.

Very truly yours,

/s/ KPMG LLP

v3.24.3
Cover
Apr. 25, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Oct. 25, 2024
Entity Registrant Name CONCENTRIX CORPORATION
Entity Incorporation, State or Country Code DE
Entity File Number 001-39494
Entity Tax Identification Number 27-1605762
Entity Address, Address Line One 39899 Balentine Drive
Entity Address, City or Town Newark
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94560
City Area Code 800
Local Phone Number 747-0583
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol CNXC
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001803599
Amendment Flag false
Entity Address, Address Line Two Suite 235
Concentrix (NASDAQ:CNXC)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Concentrix Charts.
Concentrix (NASDAQ:CNXC)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Concentrix Charts.